Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 120 (RN7SKP120) is a non-coding RNA pseudogene. It is one of many genomic loci that are unprocessed/processed vestiges of the parental RN7SK gene, which encodes a small nuclear RNA involved in regulation of transcription elongation by RNA Polymerase II through sequestration of P-TEFb[2][3][4][6]. There are more than 1,000 such pseudogenes related to small nuclear RNA genes in the human genome, most presumed to be unexpressed and non-functional[1]. RN7SKP120 is not a functional gene, does not produce a product, is not classified as a receptor or other drug target, and currently lacks evidence for a biological or pathological role in disease[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 120 (RN7SKP120).